RCG
LGND icon

Ruggie Capital Group’s Ligand Pharmaceuticals LGND Stock Holding History

Ruggie Capital Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14
Closed -$1K – 194
2019
Q2 		$1K Buy
+14
New +$1.03K ﹤0.01% 258

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Ruggie Capital Group's LGND Position: Q3 2019 in Review

Ruggie Capital Group sold out of Ligand Pharmaceuticals (LGND) in Q3 2019, closing a stake of 14 shares — an estimated $1K sold.

Ruggie Capital Group first reported a position in LGND in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 275 funds tracked by Wall St. Rank hold LGND as of Q3 2019.

  • Ruggie Capital Group reported no remaining Ligand Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Ruggie Capital Group sold 14 Ligand Pharmaceuticals shares in Q3 2019, an estimated $1K.
  • Ruggie Capital Group first reported a position in Ligand Pharmaceuticals in Q2 2019 and held it in 1 quarter.
  • Ruggie Capital Group's Ligand Pharmaceuticals position peaked at $1K in Q2 2019.
  • 275 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2019.

Based on Ruggie Capital Group's 13F filing for Q3 2019, filed 6 Nov 2019.